Paragon Private Wealth Management’s VanEck Biotech ETF BBH Stock Holding History

Paragon Private Wealth Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.89M	Buy	15,368 +775	+5%	+$149K	0.9%	22
2025 Q4	$2.76M	Buy	14,593 +1,199	+9%	+$222K	0.85%	23
2025 Q3	$2.22M	Buy	13,394 +9,254	+224%	+$1.51M	0.73%	33
2025 Q2	$635K	Buy	+4,140	New	+$617K	0.25%	111

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

Paragon Private Wealth Management's BBH Position: Q1 2026 in Review

Paragon Private Wealth Management increased its VanEck Biotech ETF (BBH) stake by 5.3% in Q1 2026, buying an estimated $149K and bringing the position to 15,368 shares worth $2.89M. The position accounts for 0.9% of the portfolio, ranked #22.

Paragon Private Wealth Management first reported a position in BBH in Q2 2025 and has held it in 4 quarters since. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

Paragon Private Wealth Management held 15,368 shares of VanEck Biotech ETF worth $2.89M as of Q1 2026.
Paragon Private Wealth Management bought 775 VanEck Biotech ETF shares in Q1 2026, an estimated $149K.
VanEck Biotech ETF made up 0.9% of Paragon Private Wealth Management's portfolio in Q1 2026, its #22 holding.
Paragon Private Wealth Management first reported a position in VanEck Biotech ETF in Q2 2025 and has held it in 4 quarters since.
112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Paragon Private Wealth Management's 13F filing for Q1 2026, filed 19 May 2026.